SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-045089
Filing Date
2022-04-12
Accepted
2022-04-12 16:31:18
Documents
8
Period of Report
2022-04-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2212382d1_6k.htm 6-K 16465
2 EXHIBIT 99.1 tm2212382d1_ex99-1.htm EX-99.1 41826
3 EXHIBIT 99.2 tm2212382d1_ex99-2.htm EX-99.2 28754
4 EXHIBIT 99.3 tm2212382d1_ex99-3.htm EX-99.3 18391
5 EXHIBIT 99.4 tm2212382d1_ex99-4.htm EX-99.4 1022181
6 GRAPHIC tm2212382d1_ex99-1img028.jpg GRAPHIC 3543
7 GRAPHIC tm2212382d1_ex99-2img001.jpg GRAPHIC 9818
8 GRAPHIC tm2212382d1ex99-3img003.jpg GRAPHIC 11957
  Complete submission text file 0001104659-22-045089.txt   1163972
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 22822635
SIC: 2836 Biological Products, (No Diagnostic Substances)